产品名称 | NebuSelect™ Recombinant Biotinylated Human LILRB1/CD85j/ILT2, Avi-His-tag |
---|---|
目录号 | NBL-242344 |
别名 | LILRB1/CD85j/ILT2; ILT2; ILT-2; ILT2FLJ37515; LILRB1; LIR1; MIR7; CD85J; XXbac-BCX85G21.4 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q8NHL6-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242344-100ug | 100ug | Inquire | Inquire | |
NBL-242344-1mg | 1mg | Inquire | Inquire | |
NBL-242344-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human LILRB1/CD85j/ILT2, Avi-His-tag
Catalog#:
NBL-242344
Description:
NebuSelect™ Recombinant Biotinylated Human LILRB1/CD85j/ILT2, Avi-His-tag(Cat#NBL-242344) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly24-His458.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 50 kDa. Due to glycosylation, the protein migrates to 65-75 kDa based on Bis-Tris PAGE result.
Target Name:
LILRB1/CD85j/ILT2; ILT2; ILT-2; ILT2FLJ37515; LILRB1; LIR1; MIR7; CD85J; XXbac-BCX85G21.4
Target Information:
LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family. Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs.LILRB1 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.